C57BL/6N-Nbeaem1Kili/Ieg

Status

Available to order

EMMA IDEM:14919
Citation informationRRID:IMSR_EM:14919 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6N-Nbeaem1Kili/Ieg
Alternative nameNbea-em1Kili (official allele design.; MGI:7262988) lab. design.: Nbea-KI (L1085A)
Strain typeEndonuclease-mediated
Allele/Transgene symbolNbeaem1Kili
Gene/Transgene symbolNbea

Information from provider

ProviderManfred Kilimann
Provider affiliationMolecular Neurobiology, Max-Planck-Institute für Interdisciplinary Sciences
Genetic informationThis mutant mouse line carries a single amino acid replacement in exon 22 (amino acid 1085) of its endogenous neurobeachin gene (Nbea). This amino acid replacement abolishes the ability of the Nbea protein to bind the regulatory subunit of protein kinase A, i.e. it abolishes Nbea's A-kinase anchoring protein (AKAP) activity. Mutagenesis was performed at Cyagen by CRISPR/Cas-mediated genome engineering. The L1085A (TTG to GCG) mutation was introduced into exon 22 by homology-directed repair. An additional silent mutation (GCC to GCG) was introduced nearby to prevent the binding and re-cutting of the sequence by gRNA after homology-directed repair.
Phenotypic informationHomozygous:
No phenotype detected to date. The L1085A missense mutation was introduced to investigate the biological role of the protein kinase A-binding propensity of Nbea (AKAP activity). As Nbea's AKAP activity is conserved between Drosophila and mammals, a biological significance is likely, and is expected primarily in the context of nervous system development and/or plasticity. However, no phenotype has been detected to date in the standard phenotyping screen of the German Mouse Clinic, or in additional behavioral and electrophysiological tests.

Heterozygous:
No phenotype.
Breeding historyThe mutation was generated in C57BL/6N mice and mice were subsequently backcrossed to C57BL/6N for 7 generations.
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6N males

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • preweaning lethality, complete penetrance / IMPC
  • abnormal embryo size / IMPC
  • abnormal body wall morphology / IMPC
  • decreased bone mineral content / IMPC
  • decreased lean body mass / IMPC
  • decreased bone mineral density / IMPC
  • increased total body fat amount / IMPC
  • cleft palate / IMPC

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).